当前位置：首页>产品中心>单抗/多抗>Anti-Human CD265/TNFRSF11A Polyclonal Antibody|抗人CD265/TNFRSF11A多克隆抗体(靶标：人肿瘤坏死因子受体超家族成员11A/RANK/CD265)
Anti-Human CD265/TNFRSF11A Polyclonal Antibody|抗人CD265/TNFRSF11A多克隆抗体(靶标：人肿瘤坏死因子受体超家族成员11A/RANK/CD265)
- 货号：RB9THV008014
- 价格：面议
- 点击：219
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Rabbit |
| 克隆性 | Polyclonal |
| 抗体亚型 | IgG |
| 纯化方式 | Purified by antigen affinity column. |
| 内毒素水平 | Please contact with the lab for this information. |
| 应用 | ELISA, IHC, WB |
| 种属反应性 | Human |
| 靶标 | CD265, ODFR, Osteoclast differentiation factor receptor, RANK, Receptor activator of NF-KB, TNFRSF11A, Tumor necrosis factor receptor superfamily member 11A |
| 免疫原 | E. coli - derived recombinant Human CD265/TNFRSF11A (Ser36-Ser195). |
| 储存缓冲液 | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| 产品使用说明 | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
| 登录号 | Q9Y6Q6 |
| 背景信息 | Tumor necrosis factor receptor superfamily member 11A (CD265/TNFRSF11A) is a ~66 kDa protein. Receptor for TNFSF11/RANKL/TRANCE/OPGL; essential for RANKL-mediated osteoclastogenesis. Its interaction with EEIG1 promotes osteoclastogenesis via facilitating the transcription of NFATC1 and activation of PLCG2. Involved in the regulation of interactions between T-cells and dendritic cells. 1. Nakagawa, N. et al. (1998) Biochemical and biophysical research communications 253, 395-400. PMID: 9878548 |
| 备注 | For research use only |
相关产品:
| 产品名称 | 点击数 |
|---|---|
| 倍硫磷单抗 | 6363 |
| 多菌灵/阿苯达唑二合一单抗 | 6455 |
| 三氯噻嗪单抗 | 6546 |
| 吡唑醚菌酯单抗 | 6795 |
| 烯酰吗啉单抗 | 6649 |
| 抑霉唑单抗 | 6307 |
| 恶醚唑（苯醚甲环唑）单抗 | 6473 |
| 赛拉嗪（甲苯噻嗪）单抗 | 6498 |
| 辛硫磷单抗 | 6586 |
| 多效唑单抗 | 6476 |
| 对硫磷单抗 | 6671 |
| 丙溴磷单抗 | 6720 |
| 戊唑醇单抗 | 6729 |
| 莠去津单抗 | 6576 |
| 灭蝇胺单抗 | 6252 |
| 尼卡巴嗪代谢物（DNC）单抗 | 6531 |
| 2.4-二氯苯氧乙酸单抗 | 6370 |
| 甲基对硫磷单抗 | 6437 |
| 左旋咪唑单抗 | 6396 |
| 三唑磷单抗 | 6484 |